Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NeuroRx Inc.
DescriptionA combination of D-cycloserine and an approved mood stablizer
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationDepression
Indication DetailsTreat depression and suicidality in patients with bipolar disorder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today